Results 121 to 130 of about 49,296 (268)
Patients With Pituitary Neuroendocrine Tumours Requiring Neurosurgery –Who Is Referring Them?
Clinical Endocrinology, Volume 104, Issue 4, Page 352-361, April 2026.ABSTRACT Objective Patients living with pituitary neuroendocrine tumours (PitNETs) present with a spectrum of clinical manifestations and often follow a circuitous route to diagnosis, resulting in diagnostic delays. The objective of this study is to identify and report the various sources of referrals for patients who underwent pituitary resection for ...
Doua S. Ahmed +11 more
wiley +1 more source
Alʹmanah Kliničeskoj Mediciny, 2017 Acromegaly is a rare disease with increased growth hormone secretion most often caused by pituitary adenoma. Not adequately treated acromegaly may lead to early death related to increased rates of acute cardiovascular events, sleep apnea, metabolic ...
I. D. Chikh +3 more
doaj +1 more source
National acromegaly registries.
Best practice & research. Clinical endocrinology & metabolism, 2019 Acromegaly is a rare disease, associated with multiple organs and systems damage. Thanks to implementation of registries, systematic data gathering, knowledge sharing and standardizing medical practices for optimal care greatly improved.
L. Maione, P. Chanson
semanticscholar +1 more source
Journal of Clinical Endocrinology and Metabolism, 2020 BACKGROUND Vertebral fractures (VFs) are a frequent complication of acromegaly, but no studies have been so far published on effectiveness of anti-osteoporotic drugs in this clinical setting. OBJECTIVE To evaluate whether in real-life clinical practice
G. Mazziotti +29 more
semanticscholar +1 more source
European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids
Journal of Neuroendocrinology, Volume 38, Issue 4, April 2026.Abstract This ENETS guidance paper, developed by a multidisciplinary working group, provides up‐to‐date and practical advice on the diagnosis and management of lung and thymic carcinoids, based on recent developments and study results. These recommendations aim to provide practical recommendations for the diagnosis, treatment and follow‐up of these ...
Eric Baudin +12 more
wiley +1 more source
Sclerostin levels in patients with acromegaly
Endokrynologia PolskaAcromegaly is a rare, endocrine condition characterized by autonomous excessive secretion of growth hormone, causing numerous complications, including impairment of bone microarchitecture.
Arnika Wydra +4 more
doaj +1 more source
BACKGROUND CHANGES OF THE DIGESTIVE SYSTEM MUCOSA IN PATIENTS WITH ACROMEGALY
Alʹmanah Kliničeskoj Mediciny, 2016 Background: Gastrointestinal tract lesions due to the growth hormone impact on mucosa of both the stomach and colon contribute to the complications of acromegaly.
A. A. Titaeva +4 more
doaj +1 more source
Bromocriptine-associated ototoxicity [PDF]
, 2007 Three patients treated with bromocriptine for chronic hepatic encephalopathy showed audiometric evidence of bilateral sensori-neural hearing-loss. Audiometrically, the hearing improved in all three patients when the bromocriptine dosage was reduced, thus
Ballantyne, J, Lanthier, PL, Morgan, MY
core +1 more source
Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis.
European Journal of Endocrinology, 2018 OBJECTIVE To compare the acromegaly mortality rates with those expected for the general population from studies published before and after 2008. METHODS We performed a systematic review and included observational studies in which the number of deaths ...
Fernanda Bolfi +3 more
semanticscholar +1 more source
Journal of Neuroendocrinology, Volume 38, Issue 4, April 2026.Abstract The chemokine network in the microenvironment of pituitary neuroendocrine tumours (PitNETs) may modulate tumour biology, aggressiveness, and treatment responses. We aimed to study the role of various chemokines and chemokine receptors in defining PitNET phenotype and clinical outcomes.
Ana Luísa Silva +13 more
wiley +1 more source